Read Simon

CIK 00016881992 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001688199

Recent Transactions

38 trades

Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-05-22+25,000→ 25,000 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−25,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−55,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Restricted Stock Units
2020-04-02−9,166→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Common Stock
2020-04-02$48.00/sh−12,595→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−26,422→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−67,500→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−107,000→ 0 total
Disposition to Issuer
Ra Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-04-02−46,434→ 0 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-12-17$2.87/sh+10,000→ 16,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-12-17−10,000→ 46,142 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-12-17$47.08/sh−10,000→ 6,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-11-14−10,000→ 56,142 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-11-14$46.68/sh−10,000→ 6,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-11-14$2.87/sh+10,000→ 16,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-10-16$2.87/sh+10,000→ 16,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-10-16−10,000→ 66,142 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-10-16$46.87/sh−10,000→ 6,234 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-09-12$25.41/sh−10,000→ 6,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-09-12−10,000→ 76,142 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-09-12$2.87/sh+10,000→ 16,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-08-23−10,000→ 86,142 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-08-23$27.77/sh−10,000→ 6,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-08-23$2.87/sh+10,000→ 16,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-07-17−10,000→ 96,142 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-07-17$32.95/sh−10,000→ 6,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-07-17$2.87/sh+10,000→ 16,234 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-06-18$22.21/sh−9,586→ 6,648 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Stock Options (Right to buy)
2019-06-18−10,000→ 106,142 total
Sale
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-06-18$23.09/sh−414→ 6,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-06-18$2.87/sh+10,000→ 16,234 total
Tax Payment
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-02-01$21.00/sh−2,933→ 6,234 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
COMMON STOCK
2019-02-01+9,167→ 9,167 total
Award
Ra Pharmaceuticals, Inc.
Options to Purchase Common Stock
2019-02-01+107,000→ 107,000 total
Exercise/Conversion
Ra Pharmaceuticals, Inc.
Restricted Stock Units
2019-02-01−9,167→ 18,333 total
Award
Ra Pharmaceuticals, Inc.
Options to Purchase Common Stock
2018-02-01+55,000→ 55,000 total
Award
Ra Pharmaceuticals, Inc.
Restricted Stock Unit
2018-02-01+27,500→ 27,500 total
Award
Ra Pharmaceuticals, Inc.
Options to Purchase Common Stock
2017-02-01+67,500→ 67,500 total

Companies

Recent Filings

Address

C/O DIANTHUS THERAPEUTICS, INC. 7 TIMES SQUARE, 43RD FLOOR

NEW YORK, NY, 10036

View on SEC.gov